Recently Approved Drug By U.S FDA

Date of Approval: July 16, 2009

The U.S. Food and Drug Administration (FDA) has approved Onsolis (fentanyl buccal soluble film) for the management of breakthrough pain in patients with cancer.

Onsolis consists of a small, dissolvable, polymer film, formulated with the opioid narcotic fentanyl for application to the buccal mucosa (inner lining of the cheek). Onsolis adheres to the buccal mucosa in seconds, starts to dissolve in minutes and delivers fentanyl across the mucosa for relief of breakthrough pain (BTP) in patients with cancer, eighteen years of age and older, who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.

Link : http://www.drugs.com/onsolis.html